{"id":"W4403924352","doi":"10.1093/cid/ciae435","title":"2024 Clinical Practice Guideline Update by the Infectious Diseases Society of America on the Management of COVID-19: Anti-SARS-CoV-2 Neutralizing Antibody Pemivibart for Pre-exposure Prophylaxis","year":2024,"lang":"en","type":"article","venue":"Clinical Infectious Diseases","topic":"SARS-CoV-2 and COVID-19 Research","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"ca_institutions":"McMaster University; Impact","funders":"Centers for Disease Control and Prevention; Infectious Diseases Society of America","keywords":"Guideline; Medicine; Coronavirus disease 2019 (COVID-19); Intensive care medicine; Grading (engineering); Food and drug administration; Coronavirus; Authorization; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Pandemic; Infectious disease (medical specialty); Disease; Medical emergency; Internal medicine; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009232288,0.001335812,0.003429814,0.005543176,0.001148763,0.003369942,0.003141072,0.007622963,0.01193641],"category_scores_gemma":[0.04598052,0.001033387,0.00557245,0.004646876,0.0008451411,0.002384422,0.002037994,0.007444189,0.008362984],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.004862528,"about_ca_system_score_gemma":0.01940536,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.02329131,"about_ca_topic_score_gemma":0.05675273,"domain_scores_codex":[0.9878939,0.004229922,0.00342667,0.0004448607,0.003579197,0.0004255001],"domain_scores_gemma":[0.9656268,0.01022797,0.005085769,0.0005455905,0.01718402,0.001329855],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0000704604,0.00008774627,0.0004940652,0.01292243,0.0003181861,0.0002265164,0.0001707641,0.0002827792,0.0003395074,0.001623096,0.8177184,0.165746],"study_design_scores_gemma":[0.0005632465,0.0001237266,0.002621218,0.07474908,0.001175763,0.0007120071,0.0001264055,0.0004044755,0.0002226189,0.0031528,0.9160726,0.00007595601],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"review","genre_gemma":"editorial","genre_scores_codex":[0.002075879,0.4062587,0.01602102,0.4017943,0.02845218,0.01224061,0.02303894,0.0009997876,0.1091187],"genre_scores_gemma":[0.0111865,0.5870051,0.1223386,0.183838,0.01541274,0.0151153,0.03309472,0.0004147714,0.03159418],"genre_candidate":"editorial","genre_consensus":null,"teacher_disagreement_score":0.02329131,"threshold_uncertainty_score":0.04882556,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0669193860161311,"score_gpt":0.4796306001903398,"score_spread":0.4127112141742086,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}